维普中文期刊产品整合服务
53篇 您的检索式:作者名="Yamada SD"
    题名 作者 年代 出处 被引量
1Mitogen-activated protein kinase kinase 4(MKK4)act s as a metastasis suppressor gene in human ovarian carcinoma显示文摘Yamada SD Hickson JA Hrobowski Y 2002Cancer Res2002,62,22:1
2A phase I study of weekly temsirollmus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies 显示文摘Temkin SM Yamada SD Fleming GF 2010Gynecologic Oncology2010,117,3:1
3Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues显示文摘Melhem A Yamada SD Fleming GF 2009Clin Cancer Res2009,15,9:1
4Altered expression of transformation growth factor-β ligands and receptors in primary and recurrent ovarian carcinoma显示文摘 Rae LB Yamada SD 1999Cancer1999,85,:1
5Intensity-modula- ted radiotherapy as a means of reducing dose to bone mar- row in gynecologic patients receiving whole pelvic radio-therapy显示文摘Lujan AE Mundt A J Yamada SD 2003Int J Radiat Oneol Biol Phys2003,57,2:1
6Ovarian carcinoma cell cultures are resistant to TGF- beta1- mediated growth inhibition despite expression of functional receptors 显示文摘Yamada SD Baldwin RL Karlan BY 1999Gynecol Oncol1999,75,1:1
7Outcome and pattern of failure in pathologic stage ⅠⅡ papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy显示文摘Mehta N Yamada SD Rotmensch J 2003Int J Radiat Oncol Biol Phys2003,57,:1
8Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors显示文摘Yamada SD Baldwin RL Karlan BY 1999Gynecol Oncol1999,75,:1
9Ovarian carcinoma cell cultures are resistant to TGF - beta - mediated growth inhibition despite ex- pression of functional receptors 显示文摘Yamada SD Baldwin RL Karlan BY 2002Gyneeol Oncol2002,75,:1
10Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotie genes SGK1 and MKP1/DUSP1 in ovarian tissues 显示文摘Melhem A Yamada SD Fleming GF 2009Clin Cancer Res2009,15,9:1
11Outcome and pattern of failure in pathologic Stage Ⅰ-Ⅱ papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy显示文摘Mehta N Yamada SD Rotmensch J 2003Int J Radiat Oncol Biol Phys2003,57,4:1
12The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma显示文摘Bishop EA Lengyel ER Yamada SD 2011Gynecol Oncol2011,121,1:1
13The expression of hepatocyte growth factor(HGF) and c-Met in uterine serous carcinoma显示文摘Bishop EA Lengyel ER Yamada SD 0,,01:1
14Outcome and patterns of failure in pathologic stages Ⅰ-Ⅳ dear-cel carcinoma of the endometrinm:implications for adjuvant radiation therapy 显示文摘Murphy KT RotmenschJ Yamada SD 2003IntJ Radlat Oucol Biol Phys2003,55,5:1
15A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies 显示文摘Temkin SM Yamada SD Fleming GF 2010Gynecologic oncology2010,117,3:1
16Stage Ⅱ C small cell carcinoma of the ovary: survival with conservative surgery and chemotherapy 显示文摘Rana S Warren BK Yamada SD 2004Obst g: Gyne2004,103,52:1
17Absence of tight junction formation in an allogeneic graft cell line used for developing an engineered artificial salivary gland 显示文摘Aframian DJ Tran SD Cukierman E Yamada KM Baum BJ 2002Tissue Eng2002,8,5:1
18A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and / or recurrent gynecologic malignan- cies显示文摘Temkin SM Yamada SD Fleming GF 2010Gyneeol Oncol2010,117,3:1
19Administration of glucocortieoids to ovarian cancer patients is associated with ex- pression of the anti-apoptotic genes SGK1 and MKPI/DUSP1 in ovarian tissues 显示文摘Melhem A Yamada SD Fleming GF 2009Clin Cancer Res2009,15,9:1
20Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma显示文摘Bristow RE Baldwin RL Yamada SD etal 1999Canoer1999,85,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费